Skip to content

Lipid Screening Study

Prospective Screening for Elevated Lipoprotein(a) in an Adult Primary Care Population

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07579325
Enrollment
35
Registered
2026-05-12
Start date
2026-05-05
Completion date
2026-07-28
Last updated
2026-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lipoprotein (a)

Keywords

lipoprotein (a), HDL and LDL, HDL, LDL, lipid Panel

Brief summary

The purpose of this pilot study is to estimate the prevalence of elevated Lipoprotein (a) in an adult primary care population and to describe the distribution of atherogenic lipid markers within this cohort. This pilot study will provide preliminary data to inform future cardiovascular risk assessment initiatives in primary care.

Interventions

OTHERVenipuncture

The study procedures include a single venipuncture (10 mL) performed for research purposes to obtain blood samples for laboratory analysis of lipoprotein(a), apolipoprotein B, and a lipid panel with reflex to direct Low-Density Lipoprotein (LDL) cholesterol measurement. The lipid panel includes total cholesterol, triglycerides, High-Density Lipoprotein (HDL) cholesterol, and calculated non-HDL cholesterol and cholesterol/HDL ratio. If triglyceride levels exceed the laboratory threshold for accurate calculation of LDL cholesterol, a direct LDL cholesterol assay will be performed per standard laboratory protocol. In addition, the study includes abstraction of demographic and clinical information from the electronic medical record (EMR), including age, sex, BMI, comorbid conditions, and cardiovascular history. All laboratory analyses will be performed using standard clinical laboratory assays. No investigational drugs or medical devices are being used in this study.

Sponsors

University of Central Florida
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Adults aged 18 years or older * Receiving care at UCF Health primary care clinic * Able to understand and provide informed consent and HIPAA authorization

Exclusion criteria

* Patient self discloses any medical condition that would make venipuncture unsafe * Pregnant women

Design outcomes

Primary

MeasureTime frameDescription
Lipoprotein(a) prevalence in Adults3 monthsThe purpose of this pilot study is to estimate the prevalence of elevated Lipoprotein (a) in an adult primary care population and to describe the distribution of atherogenic lipid markers within this cohort. This pilot study will provide preliminary data to inform future cardiovascular risk assessment initiatives in primary care.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORStephanie Perez, MSN, MBA, ARNP, CLS, BHCN

University of Central Florida

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 31, 2026